Abstract
The demand for Continuous Glucose Monitoring systems is increasing among type 1 diabetic patients. Some companies are trying to improve the monitoring and the usability of these systems. One example is Abbott FreeStyle Libre, which provides a new concept of glucose monitoring called Flash Glucose Monitoring which is more affordable and does not need calibration. The increasing demand for these devices means an opportunity for data and computer scientists, who can contribute to the development of decision-making support systems based on the data collected from the devices. Type 1 diabetic patients that use FreeStyle Libre may enter the number of insulin and carbohydrates units that they are going to take before a meal. Using both the entered data and the blood glucose values collected by the device automatically, the application presented in this paper generates a report of the patient’s glucose patterns. In addition, it provides a web application that allows the user to upload the data obtained from the device and download the report on his computer or smartphone. The application uses decision trees to detect the patterns and entails a starting point in the creation of ensemble models with more predictive power, also based on decision trees. Furthermore, the methodology makes a segmentation of the dataset in blocks, determined by the different meals done throughout the day, adding more information to the set of variables used to train the model. As a result, the application can discover repetitive patterns in the daily life of the patient, which can help to take early preventive measures for risk situations in a period close to the next meal.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Fundación Eugenio Rodríguez Pascual 2019-2020. Ministerio de Economía y Competitividad under grant TIN2014-54806-R. Ministerio de Ciencia, Innovación y Universidades under grant RTI2018-095180-B-I00. Comunidad de Madrid under grant B2017/BMD3773 (GenObIA-CM).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Hospital Universitario Príncipe de Asturias, Alcála de Henares, Madrid, Spain. Project identification code: GANIMEDES-HERACLES, on April 2013.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data of the patients is not publicly available. It could be available on demand and after signing a Non Discluser Agreement.
